Chang Tian

Principal Engineer at Moderna Therapeutics

Chang Tian, Ph.D., is a Principal Engineer at Moderna since August 2020, specializing in lipid nanoparticle formulation and process development, leveraging fundamental science, advanced experimental techniques, and computational fluid dynamics (CFD) simulation. Prior roles include Senior Engineer I and Senior Engineer II in lipid nanoparticle process science. Chang Tian's earlier experience includes a research and development internship at Evonik, focusing on hot melt extrusion and spray drying of modified release dietary supplements. Educational credentials include a Ph.D. in Chemical Engineering from Princeton University and a B.S. in Chemical and Biomolecular Engineering from Rice University.

Links


Org chart

Timeline

  • Principal Engineer

    April, 2024 - present

  • Senior Engineer II

    April, 2022

  • Senior Engineer I

    August, 2020